Similar articles

• Mortality rates and hemorrhagic complications in asian-pacific islanders during treatment of acute myocardial infarction.

  Kuo PI, Severino R, Pashkow FJ. Kuo PI, et al. Am J Cardiol. 2004 Sep 1;94(5):644-6, A9. doi: 10.1016/j.amjcard.2004.05.032. Am J Cardiol. 2004. PMID: 15342299
• [Pulmonary hemorrhage after thrombolysis in acute myocardial infarct].

  Rodríguez Blanco VM, Barriales Alvarez V, Morís de la Tassa C. Rodríguez Blanco VM, et al. An Med Interna. 1997 Apr;14(4):209. An Med Interna. 1997. PMID: 9181820 Review. Spanish. No abstract available.
• Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel--Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38).

  Hochholzer W, Wiviott SD, Antman EM, Contant CF, Guo J, Giugliano RP, Dalby AJ, Montalescot G, Braunwald E. Hochholzer W, et al. Circulation. 2011 Jun 14;123(23):2681-9. doi: 10.1161/CIRCULATIONAHA.110.002683. Epub 2011 May 23. Circulation. 2011. PMID: 21606391 Clinical Trial.
• Small-molecule glycoprotein IIb/IIIa antagonists and bleeding risk in women: too much of a good thing?

  Leopold JA. Leopold JA. Circulation. 2006 Sep 26;114(13):1344-6. doi: 10.1161/CIRCULATIONAHA.106.647883. Circulation. 2006. PMID: 17000918 No abstract available.
• Use of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.

  Fernandez JS, Sadaniantz A. Fernandez JS, et al. Med Health R I. 2001 Feb;84(2):37-43. Med Health R I. 2001. PMID: 11272658 Review. No abstract available.